| The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors (NCT05131815) | Cedars-Sinai Medical Center | 2022-07-25 |
| Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts (NCT04473794) | Johns Hopkins University | 2022-07-20 |
| Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and Outcomes (NCT05518643) | University of Thessaly | 2022-07-15 |
| A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma (NCT05336266) | Andrew Hendifar, MD | 2022-07-01 |
| ARGONAUT: Stool and Blood Sample Bank for Cancer Patients (NCT04638751) | Persephone Biosciences | 2022-07-01 |
| Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection (NCT05517811) | University of Colorado, Denver | 2022-06-26 |
| Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) (NCT05403177) | University Health Network, Toronto | 2022-06-23 |
| Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas (NCT05216120) | HonorHealth Research Institute | 2022-06-14 |
| ctDNA Assay in Patients With Resectable Pancreatic Cancer (NCT05052671) | University of Oklahoma | 2022-05-25 |
| Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial) (NCT05191940) | EBG MedAustron GmbH | 2022-05-16 |
| Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients (NCT05580887) | Moscow Clinical Scientific Center | 2022-05-12 |
| Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical Trial (NCT05253313) | University of Aarhus | 2022-05-01 |
| Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy (NCT05251233) | Washington University School of Medicine | 2022-04-21 |
| Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer (NCT05356039) | Umeå University | 2022-04-19 |
| Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC (NCT04605913) | Mayo Clinic | 2022-04-01 |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NCT05252390) | Nuvation Bio Inc. | 2022-03-29 |
| First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer (NCT05156866) | TORL Biotherapeutics, LLC | 2022-02-02 |
| Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (NCT04812808) | Hôpital Fribourgeois | 2022-02-01 |
| Less Than 100 Hours Hospital Stay After Pancreatico-duodenectomy, RCT (NCT05192044) | National Cancer Institute, Egypt | 2021-12-25 |
| Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer (NCT05191498) | Radboud University Medical Center | 2021-12-13 |
| Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer (NCT04246203) | Ludwig-Maximilians - University of Munich | 2021-12-12 |
| Milademetan in Advanced/Metastatic Solid Tumors (NCT05012397) | Rain Oncology Inc | 2021-11-01 |
| Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors (NCT05187338) | Second Affiliated Hospital of Guangzhou Medical University | 2021-11-01 |
| Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing (NCT04981119) | A2 Biotherapeutics Inc. | 2021-10-29 |
| Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer (NCT05068752) | HonorHealth Research Institute | 2021-10-28 |
| CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab (NCT05121038) | Anup Kasi | 2021-10-20 |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes (NCT04907643) | Cedars-Sinai Medical Center | 2021-10-05 |
| Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma (NCT04862260) | CHU de Quebec-Universite Laval | 2021-10-04 |
| HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors (NCT05124743) | Alaunos Therapeutics | 2021-09-24 |
| Evaluation of Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) for the Diagnosis of Pancreatic Adenocarcinoma. (NCT04851106) | GCS Ramsay Santé pour l'Enseignement et la Recherche | 2021-09-21 |
| Prognostic Factors in Periampullary Tumors and Cysts (NCT05155878) | Umeå University | 2021-09-01 |
| Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma (NCT04331041) | Washington University School of Medicine | 2021-08-24 |
| Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients (NCT04536077) | Washington University School of Medicine | 2021-08-13 |
| Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma (NCT05248750) | Catholic University of the Sacred Heart | 2021-07-22 |
| Stereotactic PAncreatic RadioTherapy Adjuvant Therapy (NCT05043857) | Istituto Clinico Humanitas | 2021-07-06 |
| Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients (NCT04843306) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-06-03 |
| Multidom Remote Monitoring of Patient With Advanced Pancreatic Cancer Treated With Florinox Using the PiCaDo Plateform (NCT04263948) | GCS Ramsay Santé pour l'Enseignement et la Recherche | 2021-06-01 |
| NCI SBIR Contract for Patient Navigation Tool Prototype Development (NCT04892927) | GMG Arcdata LLC | 2021-05-03 |
| Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors (NCT04902872) | Cybrexa Therapeutics | 2021-05-03 |
| Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma. (NCT04258072) | Samsung Medical Center | 2021-04-19 |
| An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma (NCT04837833) | Memorial Sloan Kettering Cancer Center | 2021-04-06 |
| Pilot Study of 89-Zr Panitumumab in Pancreas Cancer (NCT04833959) | Stanford University | 2021-03-26 |
| Role of Pre-operative CPET in Pancreatoduodenectomy (NCT06068452) | East Lancashire Hospitals NHS Trust | 2021-03-24 |
| DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) (NCT04825834) | Delfi Diagnostics Inc. | 2021-03-22 |
| Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma (NCT04594772) | University of Cincinnati | 2021-03-17 |
| Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid (NCT04777604) | Samsung Medical Center | 2021-03-01 |
| TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma (NCT04923529) | The University of Hong Kong | 2021-03-01 |
| Relieving the Bile Ducts Prior to Pancreatoduodenectomy (NCT05434520) | Rigshospitalet, Denmark | 2021-03-01 |
| Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition (NCT04542291) | Washington University School of Medicine | 2021-02-25 |
| Evaluation of the Impact of Pancreatectomy on Systemic Immunity (NCT03978702) | Institut Paoli-Calmettes | 2021-02-24 |
| FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer (NCT04141995) | University of Nebraska | 2021-02-12 |
| INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors (NCT04436679) | University Hospital, Lille | 2021-02-02 |
| An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy (NCT04739046) | Seoul National University Bundang Hospital | 2021-02-01 |
| Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy (NCT04774198) | Rigshospitalet, Denmark | 2021-02-01 |
| SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells (NCT04150042) | General Oncology, Inc. | 2021-01-13 |
| A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma (NCT03760614) | Abramson Cancer Center at Penn Medicine | 2021-01-01 |
| Improvement of Care of Patients Undergoing Pancreaticoduodenectomy (NCT04668781) | Helsinki University Central Hospital | 2020-12-21 |
| Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients (NCT04604158) | Gillian Gresham | 2020-12-02 |
| Pancreas Cancer Surveillance Using an Abbreviated MRI (NCT04592393) | Seoul National University Hospital | 2020-10-28 |
| Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery (NCT04920019) | Mahidol University | 2020-10-22 |
| Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors (NCT04640480) | SN BioScience | 2020-10-21 |
| Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy (NCT04616131) | Northwestern University | 2020-10-01 |
| Pancreatic Cancer Early Detection Consortium (NCT04970056) | Arbor Research Collaborative for Health | 2020-09-18 |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC (NCT04140526) | OncoC4, Inc. | 2020-09-16 |
| Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. (NCT05266300) | University of Southern Denmark | 2020-09-01 |
| The Effects of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Surgical Patients (NCT04524260) | University of Zurich | 2020-08-31 |
| Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy (NCT04517019) | University Hospital Tuebingen | 2020-08-01 |
| Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury (NCT04485286) | Massachusetts General Hospital | 2020-07-19 |
| Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study) (NCT04281290) | University Medical Centre Ljubljana | 2020-07-13 |
| Evolution of Body Connection After Surgery (NCT04422730) | Institut Paoli-Calmettes | 2020-06-30 |
| Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs (NCT04687410) | Peter Vilmann MD, DSc, HC, FASGE | 2020-06-15 |
| Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors (NCT04429542) | Bicara Therapeutics | 2020-06-01 |
| Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy (NCT04571294) | Humanitas Hospital, Italy | 2020-05-26 |
| Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer (NCT04257448) | GWT-TUD GmbH | 2020-05-25 |
| Advanced Endoscopy During COVID-19 (NCT04385147) | Al-Azhar University | 2020-05-18 |
| The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients (NCT04528745) | University of Copenhagen | 2020-05-04 |
| Trainee Involvement in ERCP Risk Score (NCT04341909) | Clinical Hospital Colentina | 2020-04-01 |
| A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies (NCT04316078) | Sheba Medical Center | 2020-03-15 |
| Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions (NCT04324294) | Cedars-Sinai Medical Center | 2020-02-26 |
| Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients (NCT04269369) | Jessa Hospital | 2020-02-18 |
| Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy (NCT03956056) | Washington University School of Medicine | 2020-02-13 |
| Preoperative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer (NCT04136769) | Ulrich Ronellenfitsch, MD | 2020-02-07 |
| The Microbiome of Pancreatic Cancer: "PANDEMIC" Study (NCT04274972) | Azienda Ospedaliera Universitaria Integrata Verona | 2020-02-01 |
| National Survey and Case-vignette Study of Clinical Decisions in Pancreatic Cancer (NCT04755036) | Hospital Miguel Servet | 2020-01-01 |
| L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer (NCT04203641) | Helix BioPharma Corporation | 2019-12-11 |
| Stereotactic Magnetic Resonance Guided Radiation Therapy (NCT04115254) | Dana-Farber Cancer Institute | 2019-10-22 |
| A Pilot Study of BXCL701 in Patients With Pancreatic Cancer (NCT04123574) | BioXcel Therapeutics Inc | 2019-10-15 |
| Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology (NCT04512209) | University Hospital, Ghent | 2019-10-11 |
| A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer (NCT04080024) | Spago Nanomedical AB | 2019-08-23 |
| Effect of Preoperative Immunonutrition in Upper Digestive Tract (NCT04027088) | Complexo Hospitalario Universitario de A Coruña | 2019-08-10 |
| Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B (NCT03778879) | Alan Katz | 2019-08-01 |
| ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer (NCT04064034) | Mayo Clinic | 2019-08-01 |
| A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain (NCT04014478) | Shanghai Golden Leaf MedTec Co. Ltd | 2019-07-15 |
| Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy (NCT03883919) | Washington University School of Medicine | 2019-07-11 |
| Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy (NCT04106167) | Fate Therapeutics | 2019-06-11 |
| Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study (NCT03951324) | Innovative Digestive Health Education and Research Inc | 2019-05-10 |
| High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer (NCT03908333) | Medical College of Wisconsin | 2019-05-01 |
| Peptide-based Immunization for Colon- and and Pancreas-carcinoma (NCT03871790) | CENTOGENE GmbH Rostock | 2019-04-01 |
| Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement (NCT03716531) | Massachusetts General Hospital | 2019-03-19 |
| FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors (NCT03841110) | Fate Therapeutics | 2019-02-15 |